Please login to the form below

Not currently logged in
Email:
Password:

Good Relations appoints new executive director

Sophie Taylor-Roberts will head the agency’s health and wellbeing practice

Sophie Taylor-RobertsLondon based PR and content agency Good Relations has bolstered its senior team with new addition Sophie Taylor-Roberts, who will head up the agency’s new health and wellbeing practice as its new executive director.

She said: “Health and wellbeing has relevance to everyone and with the continuing drive towards self-care and self-empowerment in healthcare, there is an ever growing demand for high-quality, content-led communications that help educate, engage and motivate audiences on issues related to health.

“I’m looking forward to driving the Good Relations practice into a fascinating and flourishing market, and can’t wait to get going.”

The new offering will combine consumer thinking, content generation and influence engagement with healthcare knowledge to help clients engage their audience.

Roberts, who joins Good Relations after more than eight years at Red Consultancy, where she was most recently joint managing director of its Red Health arm, working with pharmaceutical and healthcare clients that included Sanofi, Janssen, and Pfizer.

Richard Moss, chief executive officer, Good Relations, said: “Sophie is hugely respected in her field with a wide range of experience.

“We’re delighted to have her on board to lead the change with our health and wellbeing practice.”

13th November 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics